Event at the National Cancer Institute in Milan.
Health is the foundation on which we build our experiences, relationships, work, and everything that gives meaning and value to our existence. Education is one of the most powerful engines to help extend life expectancy globally.
Thus, we are proud to launch the new edition of Factor J at the National Cancer Institute in Milan, an institution that for almost 100 years has been a protagonist of major clinical and health achievements in oncology.
Promoted by Johnson & Johnson, which is committed to researching and developing innovative therapies to improve the lives of people around the world, and third sector organization Fondazione Mondo Digitale, Factor J was created to promote the value of scientific progress in health in Italian schools. The project has reached 300,000 young students to date, involving 18 patient associations, three academic partners, and five institutional partners.
The 2024-25 edition marks a further step forward. We will work with students to understand how artificial intelligence is transforming the diagnosis, treatment, and management of diseases.
AGENDA
09.30 | ARRIVAL AND WELCOME COFFEE
10.00 | INTRODUCTION AND MODERATION
Elena Meli, Journalist, Corriere della Sera
10.10 | INSTITUTIONAL GREETING
- Giuseppe Valditara, Minister of Education*
- Attilio Fontana, President, Regione Lombardia*
- Gustavo Galmozzi, President, IRCCS National Cancer Institute in Milan
10.30 | TRUST IN SCIENCE: LISTENING TO THE STUDENTS
- Sit-com: “Ho preso un granchio”
- Andrea Ferrari, Paediatric Oncologist
- Carlo Alfredo Clerici, Specialist in Clinical Psychology
- “Progetto Giovani” Project
11.00 | FACTOR J: TOGETHER TOWARDS THE MEDICINE OF THE FUTURE
- Mirta Michilli, Director General, Fondazione Mondo Digitale ETS
- Mario Sturion, Managing Director, Johnson & Johnson Innovative Medicine ltalia
Interviews by Greta Onnis, student, Factor J Ambassador and author of the book entitled “È solo un momento”
11.20 | AI AND HEALTH: DATA AND APPLICATION SCENARIOS
Presentation of the results of the study coinducted by SWG on the perception of understanding of Italians of the potential of AI in health.
- Giovanni Riccardi, Data Analysis and AI Coordinator, Johnson & Johnson Innovative Medicine ltalia
- Arsela Prelaj, Oncologist, Researcher, and Coordinator of the AI Lab at the National Cancer Institute
11.40 | CONCLUSIONS
- Emanuele Monti, III Commission on Health and Social Policy, Regione Lombardia
[*] invited
